KAS
APYX icon

Kestra Advisory Services’s Apyx Medical APYX Stock Holding History

Kestra Advisory Services’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-124,189
Closed -$154K – 2658
2024
Q3 		$154K Hold
124,189
– – ﹤0.01% 2419
2024
Q2 		$166K Buy
+124,189
New +$183K ﹤0.01% 2451
2021
Q1 		– Sell
-215,380
Closed -$1.61M – 1849
2020
Q4 		$1.61M Buy
+215,380
New +$1.43M 0.02% 674

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Advisory Services's APYX Position: Q4 2024 in Review

Kestra Advisory Services sold out of Apyx Medical (APYX) in Q4 2024, closing a stake of 124,189 shares — an estimated $154K sold.

Kestra Advisory Services first reported a position in APYX in Q4 2020 and held it in 3 quarters. The position peaked at $1.61M in Q4 2020. 45 funds tracked by Wall St. Rank hold APYX as of Q4 2024.

  • Kestra Advisory Services reported no remaining Apyx Medical position as of Q4 2024 after selling out during the quarter.
  • Kestra Advisory Services sold 124,189 Apyx Medical shares in Q4 2024, an estimated $154K.
  • Kestra Advisory Services first reported a position in Apyx Medical in Q4 2020 and held it in 3 quarters.
  • Kestra Advisory Services's Apyx Medical position peaked at $1.61M in Q4 2020.
  • 45 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2024.

Based on Kestra Advisory Services's 13F filing for Q4 2024, filed 10 Feb 2025.